News | November 10, 2023
Intermountain Health files complain against Dr. Reddy’s and others
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
The inspection closed with zero observations and a classification of No Action Indicated
The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
The successful outcome of this study represents an important milestone in Dr. Reddy's commitment to make highquality biosimilar products more accessible and affordable
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Subscribe To Our Newsletter & Stay Updated
